Lear Corporation
NYSE:LEAAuto - Parts
+$2.00 today
- Market cap
- $5.18B
- Beta
- 1.25
- P/E (TTM)
- 13.5
- EPS (TTM)
- $10.35
- Dividend yield
- 2.20%
Volume 0.62M
Average 0.64M
LEA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Lear CorporationNYSE: LEA
Research & Development · Q3 FY2026 · quarter ended Oct 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +6.6% a year.
Context
- Research & development amounted to 1.7% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 386.3M USD
- Year-over-year change
- -3.2%
- 4-year CAGR
- +5.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 386.3M | -3.2% |
| FY2024 | 2024-12-31 | 399.2M | +24.9% |
| FY2023 | 2023-12-31 | 319.6M | +0.3% |
| FY2022 | 2022-12-31 | 318.8M | +2.8% |
| FY2021 | 2021-12-31 | 310.2M | — |
Research & Development vs competitors
How LEA compares with its peers on the latest reported figures
- LEA's LTM Oct 2026 research & development of $0 is the 4th highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of -100.0% is the lowest of 4, against a peer median of +4.4%.
- Research & development amounts to 0.0% of revenue for LEA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $205.71M | +4.4% | +15.1% | 7.9% | |
| LTM Sep 2026 | $157M | -14.7% | -2.0% | 3.5% | |
| LTM Jun 2026 | $114.47M | +131.8% | — | 2.1% | |
| LTM Oct 2026 | $0 | -100.0% | +6.6% | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LEA) | $0 | +4.4% | +6.5% | 0.0% | |
Competitors are the stored peer set for LEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 19.26B | 20.88B | 23.47B | 23.3B | 23.26B |
| Cost of Revenue | 17.76B | 19.31B | 21.72B | 21.46B | 21.34B |
| Gross Profit | 1.49B | 1.57B | 1.75B | 1.84B | 1.91B |
| Gross Margin | 7.8% | 7.5% | 7.4% | 7.9% | 8.2% |
| Research & Development | 310.2M | 318.8M | 319.6M | 399.2M | 386.3M |
| Selling, General & Admin | 440.5M | 486.7M | 512.7M | 499.7M | 505.7M |
| Operating Expenses | 750.7M | 805.5M | 832.3M | 898.9M | 892M |
| Depreciation & Amortization | 573.9M | 576.5M | 604.4M | 620.7M | 604.1M |
| EBITDA | 1.25B | 1.18B | 1.48B | 1.46B | 1.38B |
| EBITDA Margin | 6.5% | 5.7% | 6.3% | 6.3% | 5.9% |
| Operating Income | 743.6M | 768M | 913.6M | 944.9M | 1.02B |
| Operating Margin | 3.9% | 3.7% | 3.9% | 4.1% | 4.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 89.4M | 96.2M | 98.7M | 103.8M | 98.4M |
| Other Income / Expenses | (144.3M) | (225.6M) | (87.1M) | (162M) | (345.6M) |
| Income Before Tax | 599.3M | 542.4M | 826.5M | 782.9M | 677.1M |
| Pre-Tax Margin | 3.1% | 2.6% | 3.5% | 3.4% | 2.9% |
| Income Tax Expense | 137.7M | 133.7M | 180.8M | 191.1M | 150M |
| Net Income | 373.9M | 327.7M | 572.5M | 506.6M | 436.8M |
| Net Margin | 1.9% | 1.6% | 2.4% | 2.2% | 1.9% |
| EPS (Basic) | 6.22 | 5.49 | 9.73 | 9.02 | 8.22 |
| EPS (Diluted) | 6.19 | 5.47 | 9.68 | 8.97 | 8.15 |
| Weighted Avg Shares | 60.08M | 59.67M | 58.83M | 56.14M | 53.17M |
| Weighted Avg Shares (Diluted) | 60.42M | 59.92M | 59.12M | 56.48M | 53.59M |
Lear Corporation
NYSE:LEA
Intrinsic Alpha fair value
Locked
Current Price
$107.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.